Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Endocrinological Investigation
Published in: Journal of Endocrinological Investigation 7/2012

01-07-2012 | Original Article

Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling

Authors: F. Cetani, F. Saponaro, C. Banti, L. Cianferotti, E. Vignali, S. Chiavistelli, G. Viccica, A. Pinchera, C. Marcocci

Published in: Journal of Endocrinological Investigation | Issue 7/2012

Login to get access
Metadata
Title
Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling
Authors
F. Cetani
F. Saponaro
C. Banti
L. Cianferotti
E. Vignali
S. Chiavistelli
G. Viccica
A. Pinchera
C. Marcocci
Publication date
01-07-2012
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 7/2012
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.3275/7970

Other articles of this Issue 7/2012

Journal of Endocrinological Investigation 7/2012 Go to the issue

Original Article

Dissection of the maternal effects on puberty onset by embryo transplantation in mouse

Original Article

Glucocorticoid receptors in human epicardial adipose tissue: Role of coronary status

Original Article

Association of −55CT polymorphism of UCP3 gene with fat distribution, cardiovascular risk factors and adipocytokines in patients with Type 2 diabetes mellitus

Short Review

Maximal lipid oxidation during exercise: A target for individualizing endurance training in obesity and diabetes?

Letter to the Editor

A potentially misleading finding at somatostatin receptor scintigraphy: Focal pulmonary areas of intense accumulation without computed tomography-detectable lung lesions

Endocrinology and Art

Polyphemus
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits